Aptevo Therapeutics Inc.

Ownership Transactions Reported by 11 Insiders

Symbol
APVO on Nasdaq
Location
2401 4 Th Ave., Suite 1050, Seattle, WA

There are no Buy or Sell transactions made by insiders since 4/22/2024

Aptevo Therapeutics Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Fuad El-Hibri Director $80.6K Dec 3, 2021
Marvin L. White President and CEO, Director $40.9K Mar 2, 2025
Jeffrey G. Lamothe Evp, Coo $25.8K Mar 2, 2025
SoYoung Kwon SVP, GC, BD & Corp Affairs $23.7K Mar 2, 2025
Daphne Taylor Svp, Cfo $12K Mar 2, 2025
Zsolt Harsanyi Director $7.71K Jul 17, 2024
Daniel Abdun-Nabi Director $7.59K Jul 17, 2024
John Niederhuber Director $5.17K Jul 17, 2024
Grady Grant III Director $4.44K Jul 17, 2024
Barbara Lopez Kunz Director $4.44K Jul 17, 2024
Kevin Tang Exit Filing Nov 23, 2021

Recent Insider Transactions by Companies or Individuals for Aptevo Therapeutics Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.